The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open-label, phase 1a study of HC-5404 in patients with advanced solid tumors.
 
Arkadiusz Z. Dudek
Leadership - IGF Oncology; TTC Oncology
Stock and Other Ownership Interests - IGF Oncology; Martell diagnostic; Squarex Pharma; TTC Oncology
Consulting or Advisory Role - HiberCell
Patents, Royalties, Other Intellectual Property - IGF Oncology
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; BioNTech; Byondis; Carrick Therapeutics; Daiichi Sankyo; DAVA Oncology; Eisai; Fishawack Health; G1 Therapeutics; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; Loxo/Lilly; Merck; Novartis; Ontada/McKesson; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Stemline Therapeutics; Taiho Oncology; Veru
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; BioNTech; Byondis; Carrick Therapeutics; Daiichi Sankyo; DAVA Oncology; Eisai; Fishawack Health; G1 Therapeutics; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; Loxo/Lilly; Merck; Novartis; Ontada/McKesson; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Stemline Therapeutics; Taiho Oncology; Veru
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Agendia; Aptitude Health; AstraZeneca; Daiichi Sankyo; DAVA Oncology; Eisai; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Roche; Seagen
 
Sarina A. Piha-Paul
Consulting or Advisory Role - CRC Oncology
Research Funding - Abbvie (Inst); ABM (Inst); Acepodia (Inst); Alkermes (Inst); Aminex (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squib (Inst); Cerulean Pharma (Inst); Chugai Pharma (Inst); Cullinan Oncology (Inst); Curis (Inst); Cyclacel (Inst); Daichi Sanko (Inst); ENB Therapeutics (Inst); Epigenetix (Inst); F-Star Beta Limited (Inst); F-Star Therapeutics, Ltd. (Inst); Five Prime Therapeutics (Inst); Gene Quantum (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Helix BioPharma (Inst); Hengrui Pharmaceutical (Inst); HiberCell (Inst); Immunomedics (Inst); Incyte (Inst); Jacobio (Inst); Jiangsu Simcere Pharmaceutical Co. Ltd. (Inst); Lilly (Inst); Loxo (Inst); Lytix Biopharma (Inst); MedImmune (Inst); Medivation (Inst); Merck Sharp and Dohme Corp. (Inst); Nectin Therapeutics (Inst); NIH/NCI (Inst); Novartis (Inst); Nurix (Inst); OncoNano Inc (Inst); Pfizer (Inst); Phanes Therapeutics (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Puma Biotechnology (Inst); Purinomia (Inst); RAPT Therapeutics (Inst); Replimune (Inst); Roche/Blueprint (Inst); Seagen (Inst); Shasqi Inc. (Inst); Shasqi Inc. (Inst); Silverback Therapeutics (Inst); Synlogic (Inst); Taiho Oncology (Inst); Tallac Therapeutics, Inc. (Inst); Tesaro (Inst); Theradex (Inst); Theradex (Inst); Toragen Therapeutics, Inc. (Inst); TransThera Biosciences (Inst); Xencor (Inst); ZielBio (Inst)
 
Dipesh Uprety
Consulting or Advisory Role - AstraZeneca/MedImmune; Daiichi Sankyo/Astra Zeneca; Jazz Pharmaceuticals; Sanofi
 
Benjamin Lee Kitchens
Employment - Texas Oncology
Honoraria - Astellas Oncology; AstraZeneca
Speakers' Bureau - Astellas Oncology
Travel, Accommodations, Expenses - Astellas Oncology
 
Thomas E. Hutson
Employment - Texas Oncology
Honoraria - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer/Onyx; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelixis; Johnson & Johnson; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Johnson & Johnson (Inst); Pfizer (Inst)
 
Brian H. Rank
Employment - HealthPartners, Inc
 
Michael Stokes
Employment - HiberCell
Patents, Royalties, Other Intellectual Property - HiberCell
 
Crissy Dudgeon
Employment - HiberCell
Stock and Other Ownership Interests - HiberCell; Novo Nordisk; Regeneron
Research Funding - HiberCell
Patents, Royalties, Other Intellectual Property - HiberCell
Travel, Accommodations, Expenses - HiberCell
 
David Surguladze
Employment - CVS Pharmacy (I)
Stock and Other Ownership Interests - Lilly
 
Eric Lightcap
Employment - HiberCell
Stock and Other Ownership Interests - Takeda
Research Funding - HiberCell
Patents, Royalties, Other Intellectual Property - Takeda
 
Jeremy Drees
Employment - HiberCell, Inc
Stock and Other Ownership Interests - HiberCell, Inc
Patents, Royalties, Other Intellectual Property - HiberCell, Inc
 
Ben Harrison
Employment - HealthPartners (I); HIiberCell
Stock and Other Ownership Interests - HealthPartners (I); HiberCell
Patents, Royalties, Other Intellectual Property - Biothera
 
Richard Li
Employment - Genuity Science; GlaxoSmithKline
 
Ashley LaCayo
Employment - HiberCell
Stock and Other Ownership Interests - HiberCell
 
Paulette Mattson
Employment - HiberCell, Inc
Stock and Other Ownership Interests - HiberCell
 
Nandita Bose
Employment - HiberCell
Stock and Other Ownership Interests - HiberCell (Inst)
 
Dhamina Karim
Employment - HiberCell
Stock and Other Ownership Interests - HiberCell (Inst)
 
Michele Anne Gargano
Employment - HiberCell
Stock and Other Ownership Interests - HiberCell
Patents, Royalties, Other Intellectual Property - HiberCell
 
Jose Luis Iglesias
Consulting or Advisory Role - Amplia Therapeutics; Aucentra Therapeutics; Carina Biotech; Engine Biosciences; Epsilogen; HIberCell; Immunovaccine; Panavance Therapeutics